The selective adenosine A2A receptor antagonist SCH 58261 discriminates between two different binding sites for [3H]-CGS 21680 in the rat brain

[3H]SCH 58261, a Selective Adenosine A2A Receptor Antagonist, Is a Useful Ligand in Autoradiographic Studies

Journal of Neurochemistry ◽

10.1046/j.1471-4159.1998.70031210.x ◽

2002 ◽

Vol 70 (3) ◽

pp. 1210-1216 ◽

Cited By ~ 40

Author(s):

Bertil B. Fredholm ◽

Karin Lindström ◽

Silvio Dionisotti ◽

Ennio Ongini

Keyword(s):

Receptor Antagonist ◽

Adenosine A2a Receptor ◽

A2a Receptor ◽

Sch 58261 ◽

SCH 58261, a selective adenosine A2A receptor antagonist with potential antiparkinsonian properties

European Neuropsychopharmacology ◽

10.1016/s0924-977x(99)90173-6 ◽

1999 ◽

Vol 9 ◽

pp. S30

Keyword(s):

Receptor Antagonist ◽

Adenosine A2a Receptor ◽

A2a Receptor ◽

Sch 58261 ◽

SCH 58261 (an adenosine A2A receptor antagonist) reduces, only at low doses, K+-evoked glutamate release in the striatum

European Journal of Pharmacology ◽

10.1016/s0014-2999(01)01058-5 ◽

2001 ◽

Vol 421 (3) ◽

pp. 177-180 ◽

Cited By ~ 29

Author(s):

Annita Pintor ◽

Davide Quarta ◽

Antonella Pèzzola ◽

Rosaria Reggio ◽

Patrizia Popoli

Keyword(s):

Receptor Antagonist ◽

Glutamate Release ◽

Adenosine A2a Receptor ◽

Low Doses ◽

A2a Receptor ◽

Sch 58261 ◽

Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats

Synapse ◽

10.1002/1098-2396(20010301)39:3<233::aid-syn1004>3.0.co;2-k ◽

2001 ◽

Vol 39 (3) ◽

pp. 233-238 ◽

Cited By ~ 80

Author(s):

Annalisa Pinna ◽

Sandro Fenu ◽

Micaela Morelli

Keyword(s):

Receptor Antagonist ◽

Adenosine A2a Receptor ◽

A2a Receptor ◽

Sch 58261 ◽

6 Hydroxydopamine ◽

Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6/2 Huntington’s disease mice

Neurobiology of Disease ◽

10.1016/j.nbd.2007.07.009 ◽

2007 ◽

Vol 28 (2) ◽

pp. 197-205 ◽

Cited By ~ 49

Author(s):

M.R. Domenici ◽

M.L. Scattoni ◽

A. Martire ◽

G. Lastoria ◽

R.L. Potenza ◽

...

Keyword(s):

Huntington's Disease ◽

Receptor Antagonist ◽

Huntington’S Disease ◽

Adenosine A2a Receptor ◽

A2a Receptor ◽

Sch 58261 ◽

Adenosine A2a ◽

Electrophysiological Effects

Distribution of adenosine A2A receptor antagonist KW-6002 and its effect on gene expression in the rat brain

Brain Research ◽

10.1016/s0006-8993(02)03277-8 ◽

2002 ◽

Vol 953 (1-2) ◽

pp. 119-125 ◽

Cited By ~ 23

Author(s):

Shiro Aoyama ◽

Kumiko Koga ◽

Akihisa Mori ◽

Hiromasa Miyaji ◽

Susumu Sekine ◽

...

Keyword(s):

Gene Expression ◽

Receptor Antagonist ◽

Rat Brain ◽

Adenosine A2a Receptor ◽

A2a Receptor ◽

SCH 58261, a selective adenosine A2A receptor antagonist, decreases the haloperidol-enhanced proenkephalin mRNA expression in the rat striatum

Brain Research ◽

10.1016/s0006-8993(03)02759-8 ◽

2003 ◽

Vol 977 (2) ◽

pp. 270-277 ◽

Cited By ~ 14

Author(s):

Jadwiga Wardas ◽

Małgorzata Pietraszek ◽

Marta Dziedzicka-Wasylewska

Keyword(s):

Receptor Antagonist ◽

Mrna Expression ◽

Adenosine A2a Receptor ◽

Rat Striatum ◽

A2a Receptor ◽

Sch 58261 ◽

Proenkephalin Mrna ◽

Effects of SCH 58261, an Adenosine A2A Receptor Antagonist, on Quinpirole-Induced Turning in 6-Hydroxydopamine-Lesioned Rats Lack of Tolerance after Chronic Caffeine Intake

Neuropsychopharmacology ◽

10.1016/s0893-133x(99)00144-x ◽

2000 ◽

Vol 22 (5) ◽

pp. 522-529 ◽

Cited By ~ 31

Author(s):

P Popoli

Keyword(s):

Receptor Antagonist ◽

Adenosine A2a Receptor ◽

Caffeine Intake ◽

A2a Receptor ◽

Sch 58261 ◽

Chronic Caffeine ◽

6 Hydroxydopamine ◽

Faculty Opinions recommendation of Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1119107.577195 ◽

2008 ◽

Author(s):

Stewart Factor

Keyword(s):

Parkinson’S Disease ◽

Clinical Trial ◽

Receptor Antagonist ◽

Adenosine A2a Receptor ◽

Multicenter Clinical Trial ◽

Double Blind ◽

A2a Receptor ◽

Adenosine A2a ◽

Off Time

PBF509, an Adenosine A2A Receptor Antagonist With Efficacy in Rodent Models of Movement Disorders

Frontiers in Pharmacology ◽

10.3389/fphar.2018.01200 ◽

2018 ◽

Vol 9 ◽

Cited By ~ 9

Author(s):

Fabiana Núñez ◽

Jaume Taura ◽

Juan Camacho ◽

Marc López-Cano ◽

Víctor Fernández-Dueñas ◽

...

Keyword(s):

Receptor Antagonist ◽

Movement Disorders ◽

Adenosine A2a Receptor ◽

Rodent Models ◽

A2a Receptor ◽